; (B) $40,000,000 for fiscal year 2021; (C) $40,000,000 for fiscal year 2022; (D) $40,000,000 for fiscal year 2023; (E) $40,000,000 for fiscal year 2024; (F) $40,000,000 for fiscal year 2025; (G) $40,000,000 for fiscal year 2026; (H) $40,000,000 for fiscal year 2027; (I) $40,000,000 for fiscal year 2028; and (J) $40,000,000 for fiscal year 2029. (b) Research on the impact of substance use disorder in the workplace and on direct service providers (1) Risks of substance use disorder The Secretary, in consultation with the Director of the National Institute for Occupational Safety and Health, shall conduct (directly or through grants or contracts) research, experiments, and demonstrations, and publish studies relating to— (A) the risks faced by employees in various occupations of developing substance use disorder and of drug overdose deaths and non-fatal drug overdoses, and the formulation of prevention activities tailored to the risks identified in these occupations, including occupational injury and illness prevention; (B) the prevalence of substance use disorder among employees in various occupations; (C) efforts that employers may undertake to assist employees who are undergoing substance use disorder treatment services in maintaining employment while ensuring workplaces are safe and healthful; (D) risks of occupational exposure to opioids and other illicit substances and the formulation of prevention activities tailored to the risks identified